RIPK1 inhibitor ameliorates the MPP+/MPTP-induced Parkinson’s disease through the ASK1/JNK signalling pathway
Jing Liu, Huizheng Hu, Binyan Wu
Topics & Concepts
RIPK1MPTPASK1Cell biologyKinaseNeuroprotectionApoptosisSignal transductionChemistryBiologyProgrammed cell deathCancer researchProtein kinase APharmacologyEndocrinologyBiochemistryMitogen-activated protein kinase kinaseNecroptosisDopaminergicDopamineCell death mechanisms and regulationAlzheimer's disease research and treatmentsEndoplasmic Reticulum Stress and Disease